Edesa Biotech Inc (EDSA)
4.61
+0.10
(+2.12%)
USD |
NASDAQ |
May 10, 16:00
4.55
-0.06
(-1.30%)
After-Hours: 20:00
Edesa Biotech 1 Year Total Returns (Daily): -33.45% for May 10, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 10, 2024 | -33.45% |
May 09, 2024 | -33.52% |
May 08, 2024 | -35.00% |
May 07, 2024 | -39.08% |
May 06, 2024 | -39.62% |
May 03, 2024 | -40.91% |
May 02, 2024 | -40.85% |
May 01, 2024 | -43.71% |
April 30, 2024 | -43.33% |
April 29, 2024 | -44.26% |
April 26, 2024 | -45.09% |
April 25, 2024 | -44.00% |
April 24, 2024 | -46.92% |
April 23, 2024 | -40.94% |
April 22, 2024 | -42.06% |
April 19, 2024 | -41.14% |
April 18, 2024 | -39.70% |
April 17, 2024 | -40.70% |
April 16, 2024 | -40.88% |
April 15, 2024 | -43.40% |
April 12, 2024 | -31.18% |
April 11, 2024 | -33.33% |
April 10, 2024 | -32.93% |
April 09, 2024 | -31.68% |
April 08, 2024 | -30.03% |
Date | Value |
---|---|
April 05, 2024 | -28.96% |
April 04, 2024 | -28.59% |
April 03, 2024 | -37.57% |
April 02, 2024 | -31.09% |
April 01, 2024 | -33.59% |
March 28, 2024 | -41.86% |
March 27, 2024 | -38.58% |
March 26, 2024 | -44.99% |
March 25, 2024 | -44.22% |
March 22, 2024 | -41.21% |
March 21, 2024 | -43.82% |
March 20, 2024 | -42.86% |
March 19, 2024 | -40.96% |
March 18, 2024 | -38.23% |
March 15, 2024 | -47.74% |
March 14, 2024 | -50.17% |
March 13, 2024 | -50.71% |
March 12, 2024 | -48.00% |
March 11, 2024 | -47.89% |
March 08, 2024 | -52.43% |
March 07, 2024 | -57.44% |
March 06, 2024 | -58.07% |
March 05, 2024 | -56.55% |
March 04, 2024 | -55.17% |
March 01, 2024 | -50.57% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-89.72%
Minimum
Nov 04 2022
246.3%
Maximum
Mar 18 2021
-23.02%
Average
-45.84%
Median
Apr 20 2022
1 Year Total Returns (Daily) Benchmarks
Acasti Pharma Inc | -4.19% |
Aurinia Pharmaceuticals Inc | -55.34% |
Lexaria Bioscience Corp | 358.1% |
Xenon Pharmaceuticals Inc | -1.46% |
ESSA Pharma Inc | 122.9% |